| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000338181 |
| P698 | PubMed publication ID | 22572791 |
| P50 | author | Kaj Blennow | Q28321550 |
| P2093 | author name string | N Bogdanovic | |
| J-E Månsson | |||
| M Blomqvist | |||
| Z Pernber | |||
| P2860 | cites work | Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes | Q24532064 |
| Amyloid plaque core protein in Alzheimer disease and Down syndrome | Q24568384 | ||
| Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype | Q24642852 | ||
| Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau | Q24648590 | ||
| Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts | Q24675729 | ||
| Functional rafts in cell membranes | Q27860768 | ||
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Neuropathological stageing of Alzheimer-related changes | Q27860862 | ||
| Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria | Q29614410 | ||
| The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease | Q29614948 | ||
| Lipid rafts as a membrane-organizing principle | Q29615727 | ||
| Sites and temporal changes of gangliosides GM1/GM2 storage in the Niemann-Pick disease type C mouse brain. | Q48770929 | ||
| Cell membrane changes in brains manifesting senile plaques: an immunohistochemical study of GM1 membranous ganglioside | Q48934855 | ||
| Age-dependent high-density clustering of GM1 ganglioside at presynaptic neuritic terminals promotes amyloid beta-protein fibrillogenesis. | Q48951456 | ||
| Structure and origin of ordered lipid domains in biological membranes. | Q52186070 | ||
| Human brain gangliosides: developmental changes from early fetal stage to advanced age. | Q52244920 | ||
| Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease. | Q52539745 | ||
| GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease. | Q53199612 | ||
| Tau protein and neurodegeneration. | Q53298110 | ||
| Endosomal accumulation of GM1 ganglioside-bound amyloid beta-protein in neurons of aged monkey brains. | Q53389202 | ||
| Structural transitions associated with the interaction of Alzheimer beta-amyloid peptides with gangliosides. | Q54144813 | ||
| Frontotemporal dementia | Q56388056 | ||
| Alzheimer's disease | Q29616743 | ||
| Abeta polymerization through interaction with membrane gangliosides. | Q33527686 | ||
| Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts and caveolae (review). | Q33694188 | ||
| Lipid rafts and membrane dynamics | Q33985713 | ||
| Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts | Q34088442 | ||
| Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein | Q34649008 | ||
| The effects of normal aging on myelin and nerve fibers: a review | Q35539049 | ||
| Plasma membrane microdomains: organization, function and trafficking | Q35809659 | ||
| Consequences of NPC1 and NPC2 loss of function in mammalian neurons | Q35909562 | ||
| GM1 ganglioside and the seeding of amyloid in Alzheimer's disease: endogenous seed for Alzheimer amyloid | Q36136370 | ||
| Age-related neuropathology, cognitive decline, and Alzheimer's disease | Q36220917 | ||
| The involvement of lipid rafts in Alzheimer's disease | Q36447798 | ||
| Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis | Q36472868 | ||
| The molecular pathology of Alzheimer's disease | Q36490940 | ||
| Lipid rafts in health and disease | Q36634331 | ||
| Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review | Q36662671 | ||
| Lipid rafts and membrane traffic | Q36768730 | ||
| Frontotemporal lobar degeneration: clinical and pathological relationships | Q36849424 | ||
| Membrane rafts in Alzheimer's disease beta-amyloid production | Q37715176 | ||
| Characterization of high-affinity binding between gangliosides and amyloid beta-protein | Q38300563 | ||
| The interaction between Alzheimer amyloid beta(1-40) peptide and ganglioside GM1-containing membranes | Q38348598 | ||
| Association of active gamma-secretase complex with lipid rafts. | Q40457156 | ||
| GM1 ganglioside regulates the proteolysis of amyloid precursor protein | Q40571948 | ||
| Normal and abnormal biology of the beta-amyloid precursor protein | Q40766055 | ||
| Cholesterol-dependent formation of GM1 ganglioside-bound amyloid beta-protein, an endogenous seed for Alzheimer amyloid | Q40807391 | ||
| Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'. | Q42018527 | ||
| Characterization of the binding epitope of a monoclonal antibody to sulphatide | Q42164330 | ||
| Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains | Q43889089 | ||
| Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid | Q44014100 | ||
| Expression of the myelin and oligodendrocyte progenitor marker sulfatide in neurons and astrocytes of adult rat brain | Q44059825 | ||
| Up-and-down topological mode of amyloid beta-peptide lying on hydrophilic/hydrophobic interface of ganglioside clusters | Q44522032 | ||
| Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains | Q45192504 | ||
| Late endocytic dysfunction as a putative cause of amyloid fibril formation in Alzheimer's disease | Q46076619 | ||
| Increased cholesterol in Abeta-positive nerve terminals from Alzheimer's disease cortex | Q46839219 | ||
| CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival | Q46878198 | ||
| Accelerated Abeta aggregation in the presence of GM1-ganglioside-accumulated synaptosomes of aged apoE4-knock-in mouse brain | Q47268422 | ||
| A detergent-insoluble membrane compartment contains A beta in vivo | Q47982783 | ||
| Atypical glial cells in demyelinated and hypomyelinated mouse brains | Q48144630 | ||
| GM1-ganglioside-induced Abeta assembly on synaptic membranes of cultured neurons | Q48270632 | ||
| Differential distribution of major gangliosides in rat central nervous system detected by specific monoclonal antibodies | Q48308074 | ||
| Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons. | Q48657258 | ||
| P433 | issue | 2-3 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P1104 | number of pages | 15 | |
| P304 | page(s) | 174-188 | |
| P577 | publication date | 2012-05-10 | |
| P1433 | published in | Dementia and Geriatric Cognitive Disorders | Q15749436 |
| P1476 | title | Altered distribution of the gangliosides GM1 and GM2 in Alzheimer's disease. | |
| P478 | volume | 33 |
| Q92651158 | Amyloid Oligomers, Protofibrils and Fibrils |
| Q37243920 | Amyloid beta accumulation in HIV-1-infected brain: The role of the blood brain barrier |
| Q41074727 | Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases |
| Q34555955 | Defective macroautophagic turnover of brain lipids in the TgCRND8 Alzheimer mouse model: prevention by correcting lysosomal proteolytic deficits |
| Q55438475 | Deletion of Specific Sphingolipids in Distinct Neurons Improves Spatial Memory in a Mouse Model of Alzheimer's Disease. |
| Q36226843 | Delineating Amyloid Plaque Associated Neuronal Sphingolipids in Transgenic Alzheimer's Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry. |
| Q28391606 | Hippocampal lipid differences in Alzheimer's disease: a human brain study using matrix-assisted laser desorption/ionization-imaging mass spectrometry |
| Q28278644 | Lipid microdomain modification sustains neuronal viability in models of Alzheimer's disease |
| Q35576628 | Myelin basic protein associates with AβPP, Aβ1-42, and amyloid plaques in cortex of Alzheimer's disease brain |
| Q35915842 | Network Analysis of a Comprehensive Knowledge Repository Reveals a Dual Role for Ceramide in Alzheimer's Disease |
| Q35192627 | Neurological analyses: focus on gangliosides and mass spectrometry |
| Q39176826 | Partitioning and confinement of GM1 ganglioside induced by amyloid aggregates. |
| Q38218040 | Pathogenic role of ganglioside metabolism in neurodegenerative diseases |
| Q38125769 | Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes. |
| Q34031193 | Soluble Aβ oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes |
| Q47785630 | Soluble Oligomers Require a Ganglioside to Trigger Neuronal Calcium Overload |
| Q38691207 | The Pathogenic Role of Ganglioside Metabolism in Alzheimer's Disease-Cholinergic Neuron-Specific Gangliosides and Neurogenesis |
| Q43988916 | The impact of cholesterol, DHA, and sphingolipids on Alzheimer's disease |
| Q92193049 | Trends in Glycolipid Biomarker Discovery in Neurodegenerative Disorders by Mass Spectrometry |
Search more.